Skip to main content

Table 1 Genotypic and allelic distributions in % (n) of Eotaxin/CCL11 polymorphism in CRC patients and control subjects

From: Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine Eotaxin-1 in colorectal cancer patients

Genotype

CRC

Controls

Allele

CRC

Controls

 

(n = 241)

(n = 253)

 

(n = 482 alleles)

(n = 506 alleles)

- 384A →G

     

A/A

27.0 (65)

30.8 (78)

   
   

A

53.1 (256)

56.5 (286)

A/G

52.3 (126)

51.4 (130)

   
   

G

46.9 (226)

43.5 (220)

G/G

20.7 (50)

17.8 (45)

   
  1. CRC patients vs. controls: Not significant